← Open Payments lookup

MARIA DZIERZKO-TROJANOWSKA: Open Payments

NPI 1093806051 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 27 payments from 14 companies in 2025. Trend: 2023 $413 · 2024 $767 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$163
Astellas Pharma US Inc2$51
Sumitomo Pharma America, Inc.2$48
ABBVIE INC.3$45
GlaxoSmithKline, LLC.2$41
Novo Nordisk Inc2$33
Philips North America LLC1$26
Xeris Pharmaceuticals, Inc.1$23
Amgen Inc.1$22
Abbott Laboratories1$21

Products named: AIRSUPRA, FARXIGA, Veozah, GEMTESA, TRELEGY ELLIPTA, UBRELVY, Ambulatory Monitoring & Diagnostics Undivided, GVOKE HYPOPEN.

Industry payments across SC — which companies pay providers there.